These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9072702)

  • 1. The effect of pravastatin on coronary events after myocardial infarction.
    Auerbach I; Behar S; Motro M
    N Engl J Med; 1997 Mar; 336(13):962. PubMed ID: 9072702
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of pravastatin on coronary events after myocardial infarction.
    Hazzard WR; Ettinger WH
    N Engl J Med; 1997 Mar; 336(13):961; author reply 962. PubMed ID: 9072700
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol reduction and coronary prevention.
    Prabhakaran D
    Natl Med J India; 1997; 10(1):24-5. PubMed ID: 9069704
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of coronary heart disease with pravastatin.
    Samani NJ; de Bono DP
    N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    Ford I; Murray H; Packard CJ; Shepherd J; Macfarlane PW; Cobbe SM;
    N Engl J Med; 2007 Oct; 357(15):1477-86. PubMed ID: 17928595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program].
    Byington RP; Jukema JW; Salonen JT; Pitt B; Bruschke AV; Hoen H; Furberg CD; Mancini GB
    Fortschr Med; 1996 Mar; 114(8):91-8. PubMed ID: 8647574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
    Sacks FM; Pfeffer MA; Moye LA; Rouleau JL; Rutherford JD; Cole TG; Brown L; Warnica JW; Arnold JM; Wun CC; Davis BR; Braunwald E
    N Engl J Med; 1996 Oct; 335(14):1001-9. PubMed ID: 8801446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of mortality from coronary heart disease with pravastatin.
    Tonkin AM; Ryan EW
    Biomed Pharmacother; 1999 Oct; 53(9):405-8. PubMed ID: 10554675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering therapy for average lipid levels: the CARE trial.
    Sprecher DL
    Cleve Clin J Med; 1997 Mar; 64(3):129-31. PubMed ID: 9068221
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins and coronary artery disease--it's the clinical endpoints that count.
    Jackson G
    Br J Clin Pract; 1997; 51(1):2-3. PubMed ID: 9158261
    [No Abstract]   [Full Text] [Related]  

  • 13. Pravastatin therapy and the risk of stroke.
    Fruchter O
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117990
    [No Abstract]   [Full Text] [Related]  

  • 14. Pravastatin therapy and the risk of stroke.
    Meilof JF; Uitdehaag BM
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Victory in primary prevention--or? Can we afford to translate results from the West-of-Scotland Study into general practice?].
    Klose G
    Fortschr Med; 1996 Jun; 114(17):231-2. PubMed ID: 8767302
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention].
    Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895
    [No Abstract]   [Full Text] [Related]  

  • 17. Pravastatin shown to reduce stroke risk after heart attacks.
    Harv Heart Lett; 1999 May; 9(9):7. PubMed ID: 10198446
    [No Abstract]   [Full Text] [Related]  

  • 18. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 19. Pravastatin and coronary heart disease.
    Bloom JM
    N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol-lowering agent in men without CHD.
    Millard P; Johnson KH
    J Fam Pract; 1996 Mar; 42(3):223-4. PubMed ID: 8636668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.